Amneal Pharmaceuticals (AMRX) earnings, Nov 3, 2026: EPS +53%, stock −1.1%
In brief
Amneal Pharmaceuticals reported on Nov 3, 2026. Earnings per share changed +53% year over year, 9.5% above the estimate; revenue +10%. The stock opened with a −2.5% gap and closed the day −1.1% (Nov 3, 2026). The stock is now 10.3% below its 52-week high, +66.4% over 12 months. Next report: Feb 26, 2027.
EPS vs estimate+9.5%
EPS, YoY+53%
Revenue, YoY+10%
Gap · day−2.5% · −1.1%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Jul 30, 2026 | −3.0% | −3.1% |
| Nov 3, 2026 | −2.5% | −1.1% |
Next-quarter estimates, ratings and the AMRX chart are in the terminal.
Open the terminalFAQ
When is Amneal Pharmaceuticals's next earnings report?
Feb 26, 2027. The date comes from daily data and is corrected if the company moves it.
How did Amneal Pharmaceuticals stock react to the report?
Opening gap −2.5%, day's result −1.1%.
Did Amneal Pharmaceuticals's earnings grow?
Earnings per share rose 53% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.